Compile Data Set for Download or QSAR
Report error Found 172 Enz. Inhib. hit(s) with all data for entry = 50015654
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588258(CHEMBL5173041)
Affinity DataEC50:  2.70E+3nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588255(CHEMBL5170195)
Affinity DataEC50:  140nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM167534(US9073922, 18 | US9796708, Example 18)
Affinity DataEC50:  29nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588261(CHEMBL5170524)
Affinity DataEC50:  350nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588267(CHEMBL5209369)
Affinity DataEC50:  450nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588268(CHEMBL5187219)
Affinity DataEC50:  1.50E+3nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588269(CHEMBL5199352)
Affinity DataEC50:  750nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588270(CHEMBL5173492)
Affinity DataEC50:  430nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588271(CHEMBL5207146)
Affinity DataEC50:  510nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM167545(US9073922, 29 | US9796708, Example 29)
Affinity DataEC50:  75nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588272(CHEMBL5180640)
Affinity DataEC50:  41nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588273(CHEMBL5192311)
Affinity DataEC50:  290nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588274(CHEMBL5195947)
Affinity DataEC50:  120nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588266(CHEMBL5181709)
Affinity DataEC50:  57nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588265(CHEMBL5207813)
Affinity DataEC50:  1.70E+3nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588275(CHEMBL5175957)
Affinity DataEC50: >3.10E+4nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588276(CHEMBL5176464)
Affinity DataEC50:  420nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588263(CHEMBL5198038)
Affinity DataEC50:  17nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588277(CHEMBL5203694)
Affinity DataEC50:  340nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588278(CHEMBL5171361)
Affinity DataEC50:  450nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588279(CHEMBL5198372)
Affinity DataEC50:  66nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588280(CHEMBL5192909)
Affinity DataEC50:  1.70E+3nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588282(CHEMBL5198594)
Affinity DataEC50:  6.90E+3nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588283(CHEMBL5169733)
Affinity DataEC50:  130nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588284(CHEMBL5204473)
Affinity DataEC50:  24nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588285(CHEMBL5179773)
Affinity DataEC50:  130nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588286(CHEMBL5177440)
Affinity DataEC50:  76nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588287(CHEMBL5192022)
Affinity DataEC50:  69nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588288(CHEMBL5200778)
Affinity DataEC50:  290nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588289(CHEMBL5181511)
Affinity DataEC50:  140nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588262(CHEMBL5197170)
Affinity DataEC50:  21nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588264(CHEMBL5207871)
Affinity DataEC50:  21nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCaspase-3/Caspase-7(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588290(CHEMBL5191725)
Affinity DataEC50:  31nMAssay Description:Activation of caspase 3/7 in human MV4-11 cells incubated for 6 hrs by Caspase-Glo 3/7 reagent based microplate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588262(CHEMBL5197170)
Affinity DataKd:  0.213nMAssay Description:Binding affinity to CDK9 (unknown origin) assessed as dissociation constant by Surface Plasmon Resonance assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588262(CHEMBL5197170)
Affinity DataKon:  0.00201M-1s-1Assay Description:Binding affinity to CDK9 (unknown origin) assessed as dissociation rate constant by Surface Plasmon Resonance assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588255(CHEMBL5170195)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM167534(US9073922, 18 | US9796708, Example 18)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588261(CHEMBL5170524)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588262(CHEMBL5197170)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588263(CHEMBL5198038)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588264(CHEMBL5207871)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588263(CHEMBL5198038)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588272(CHEMBL5180640)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588266(CHEMBL5181709)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588290(CHEMBL5191725)
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588261(CHEMBL5170524)
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588273(CHEMBL5192311)
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588285(CHEMBL5179773)
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM167534(US9073922, 18 | US9796708, Example 18)
Affinity DataIC50: 6nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50588264(CHEMBL5207871)
Affinity DataIC50: 6nMAssay Description:Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
Displayed 1 to 50 (of 172 total ) | Next | Last >>
Jump to: